Back to top
more

Prestige Consumer Healthcare (PBH)

(Delayed Data from NYSE)

$59.58 USD

59.58
381,824

+0.78 (1.33%)

Updated Jul 1, 2022 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.75%
2Buy18.15%
3Hold9.70%
4Sell5.35%
5Strong Sell2.45%
S&P50010.91%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 19% (204 out of 251)

Industry: Consumer Products - Discretionary

Trades from $1

Company Summary

Based in New York, Prestige Consumer Healthcare Inc. and its subsidiaries develop, manufacture, market, sell and distributes over-the-counter (“OTC”) healthcare and household cleaning products in United States, Canada, Australia and certain other international markets. The company provides its products to mass merchandisers as well as drug, food, dollar, convenience, and club stores. Also, Prestige Consumer Healthcare operates through the e-commerce channel.

Following the divestiture of Household Cleaning segment in July 2018, Prestige Consumer reports operating results through two segments: North American OTC Healthcare and International OTC Healthcare. As of fiscal 2021, revenues in these ...

General Information

Prestige Consumer Healthcare Inc

660 WHITE PLAINS ROAD SUITE 250

TARRYTOWN, NY 10591

Phone: 914-524-6800

Fax: 302-674-5266

Web: http://www.prestigebrands.com

Email: irinquiries@prestigebrands.com

Industry Consumer Products - Discretionary
Sector Consumer Discretionary
Fiscal Year End March
Last Reported Quarter 6/30/2022
Exp Earnings Date

This is an estimated date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.

8/4/2022

EPS Information

Current Quarter EPS Consensus Estimate NA
Current Year EPS Consensus Estimate 4.19
Estimated Long-Term EPS Growth Rate 8.00
Exp Earnings Date

This is an estimated date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.

8/4/2022

Price and Volume Information

Zacks Rank Premium
Yesterday's Close 58.80
52 Week High 63.83
52 Week Low 50.40
Beta 0.51
20 Day Moving Average 288,154.94
Target Price Consensus 64.33

PBH

% Price Change
4 Week 4.24
12 Week 10.28
YTD -3.05
% Price Change Relative to S&P 500
4 Week 15.02
12 Week 31.10
YTD 22.07
Share Information
Shares Outstanding (millions) 49.92
Market Capitalization (millions) 2,935.29
Short Ratio NA
Last Split Date NA
Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

Fundamental Ratios

P/E
P/E (F1) 14.02
Trailing 12 Months 14.48
PEG Ratio 1.75
EPS Growth
vs. Previous Year 15.19%
vs. Previous Quarter -8.08%
   
Sales Growth
vs. Previous Year 12.27%
vs. Previous Quarter -2.74%
   
Price Ratios
Price/Book 1.87
Price/Cash Flow 12.16
Price / Sales 2.70
ROE
3/31/22 13.82
12/31/21 13.90
9/30/21 13.71
ROA
3/31/22 5.67
12/31/21 5.58
9/30/21 5.39
Current Ratio
3/31/22 2.04
12/31/21 2.04
9/30/21 2.05
Quick Ratio
3/31/22 1.21
12/31/21 1.25
9/30/21 1.32
Operating Margin
3/31/22 18.99
12/31/21 18.90
9/30/21 18.65
Net Margin
3/31/22 18.90
12/31/21 17.85
9/30/21 17.56
Pre-Tax Margin
3/31/22 24.15
12/31/21 22.87
9/30/21 22.51
Book Value
3/31/22 31.43
12/31/21 30.25
9/30/21 29.17
Inventory Turnover
3/31/22 4.24
12/31/21 4.13
9/30/21 3.86
Debt-to-Equity
3/31/22 0.94
12/31/21 1.01
9/30/21 1.09
Debt to Capital
3/31/22 48.42
12/31/21 50.28
9/30/21 52.24